乐和彩开户

Reimagining Patient-Centric Clinical Trials with the IoMT

discover how emerging technologies can increase clinical trial efficiency

Whitepaper

乐和彩开户the iomt can make clinical trials more efficient, effective and patient-centric. learn how.

Reimagining the Patient-Centric Clinical Trial with IoMT

with rising costs of drug and medical device development, in addition to pressures to lower prescription and procedural costs, the internet of medical things (iomt) market has grown rapidly, increasing from $41.2 billion in 2017 to an anticipated $158.1 billion in 2022.

this is because the iomt — which includes medical devices, wearable monitors and apps that connect to healthcare information systems — has the potential to increase clinical trial efficiency and improve our ability to support patients throughout the patient journey. as such, iomt is set to revolutionise clinical trials, making them more efficient, effective and manageable.

in our latest whitepaper, we follow a theoretical patient through the entire clinical trial journey – from initial contact for an early study through transition to treatment with an approved product. at each stage, we explore how iomt can increase clinical development programme efficiency by reducing the burden on patients, caregivers, pharma companies and medical device and diagnostic manufacturers.

乐优彩票天天红单下载 乐优彩票登入,备用,官方网址 乐优彩票网址是多少 乐优炫彩app 乐优炫彩app下载 乐优炫彩app天天红单 乐信pc下载 乐其彩票网站 乐优炫彩天天红单 乐优炫彩官网